Table 2.
Unadjusted and Adjusted Risk Estimates for IUGR and IUFD in Fetuses With Echogenic Bowel Compared to Those Without Echogenic Bowel After Excluding Cases of Aneuploidy and CMV Infection
| Incidence in EB group (n=231) | Incidence in Non-EB group (n=49,940) | Unadjusted RR (95% CI) | aOR (95% CI) | p-value | |
|---|---|---|---|---|---|
| IUGR | 19.5% | 12.9% | 1.6 (1.2–2.0) | 2.1* (1.5–2.9) | <0.001 |
| IUFD | 7.3% | 0.9% | 8.0 (5.0–12.8) | 9.6† (5.8–15.9) | <0.001 |
| IUFD+IUGR | 6.1% | 0.2% | 27.5 (16.0–47.2) | --- | --- |
| IUFD-IUGR | 1.3% | 0.2% | 6.2 (2.0–19.2) | --- | --- |
Adjusted for African American race, tobacco use, pre-eclampsia and pre-gestational diabetes
Adjusted for African American race
P-values are from the Wald test of the adjusted odds ratios.
IUGR=intrauterine growth restriction; IUFD=intrauterine fetal demise; EB=echogenic bowel; CMV=cytomegalovirus; RR=relative risk; aOR=adjusted odds ratio; CI=confidence interval